for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Global Cord Blood Corp

CO.N

Latest Trade

3.00USD

Change

-0.04(-1.32%)

Volume

2,707

Today's Range

2.99

 - 

3.00

52 Week Range

2.55

 - 

5.90

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
3.04
Open
2.99
Volume
2,707
3M AVG Volume
4.06
Today's High
3.00
Today's Low
2.99
52 Week High
5.90
52 Week Low
2.55
Shares Out (MIL)
121.55
Market Cap (MIL)
363.46
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Global Cord Blood Q4 Earnings Per Share RMB 0.80

Global Cord Blood Says Quarterly Revenue Rose 31.7%

Global Cord Blood Corporation Reports Q2 Earnings Per Share Rmb 0.99

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Global Cord Blood Corp

Global Cord Blood Corporation, formerly China Cord Blood Corporation, is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

Industry

Healthcare Facilities

Contact Info

48 Fl.

Bank Of China Tower, 1 Garden Road

000000

Hong Kong

+852.null.36058180

http://www.chinacordbloodcorp.com

Executive Leadership

Ting Zheng

Chairman of the Board, Chief Executive Officer, Chief Executive Officer - Beijing

Albert Chen

Chief Financial Officer, Director

Rui Arashiyama

Chief Executive Officer - Guangdong and Zhejiang Divisions

Xin Xu

Chief Technology Officer

Ping Xu

Non-Executive Director

Key Stats

Price To Earnings (TTM)
5.46
Price To Sales (TTM)
2.10
Price To Book (MRQ)
0.66
Price To Cash Flow (TTM)
4.87
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
7.59
Return on Equity (TTM)
6.94

Latest News

Latest News

BRIEF-Global Cord Blood Q4 Earnings Per Share RMB 0.80

* ORATION REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FULL YEAR OF FISCAL 2020

BRIEF-Global Cord Blood Corporation Provides Update on COVID-19

* GLOBAL CORD BLOOD - ESTIMATES CO'S NEW SUBSCRIBER NUMBER IN 2021 WILL FALL TO 60,000-65,000, 19%-29% DECREASE FROM 2020 NEW SUBSCRIBER TARGET

BRIEF-Global Cord Blood Says Quarterly Revenue Rose 31.7%

* ORATION REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF FISCAL 2020

BRIEF-Global Cord Blood Corp Provides Update On Impact Of Coronavirus

* GLOBAL CORD BLOOD CORPORATION PROVIDES UPDATE ON IMPACT OF CORONAVIRUS

BRIEF-China Cord Blood Says Shareholders Approved Co's Name Change ​

* CHINA CORD BLOOD - AT MEETING, SHAREHOLDERS APPROVED CO'S NAME TO CHANGE FROM "CHINA CORD BLOOD CORPORATION" TO "GLOBAL CORD BLOOD CORPORATION" Source text for Eikon: Further company coverage:

BRIEF-China Cord Blood Q3 Revenue RMB 245 Million

* ORATION REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF FISCAL 2018

BRIEF-China Cord Blood Corp To Change Corporate Name To "Global Cord Blood Corp"

* CHINA CORD BLOOD CORPORATION TO CHANGE CORPORATE NAME TO "GLOBAL CORD BLOOD CORPORATION" Source text for Eikon: Further company coverage:

BRIEF-Nanjing Ying Peng Becomes Major Shareholder Of China Cord Blood Corp

* NANJING YING PENG BECOMES MAJOR SHAREHOLDER OF CHINA CORD BLOOD CORPORATION

BRIEF-China Cord Blood Q2 earnings per share RMB 0.60

* China Cord Blood Corporation reports financial results for the second quarter and first half of fiscal 2018

BRIEF-Jayhawk Capital sends open letter to Sanpower Group regarding China Cord Blood Corp​

* Jayhawk Capital says sends open letter to Sanpower Group regarding China Cord Blood Corp

BRIEF-China Cord Blood Corp Q1 earnings per share RMB 0.62

* China Cord Blood Corporation reports financial results for the first quarter of fiscal 2018

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up